1. Sam IK#, Chen YY#, Ma J#, Li SY#, Ying RY, Li LX, Ji P, Wang SJ, Xu J, Bao YJ, Zhao GP, Zheng HJ, Wang J*, Sha W* and Wang Y*. TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis. Journal of Infection, 2021, 83(1):54-60.
2. Xia LL#, Wang H#, Sun MJ#, Yang Y#, Yao CC, He S, Duan HQ, Xia WM, Sun RM, Yao YX, Chen ZW, Zhao Q, Li H, Lu S, and W ang Y*. Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer. Sci China Life Sci, 2021 Jan 29. doi: 10.1007/s11427-020-1861-5. Online ahead of prin
3. Nie XQ#, Xia LL#, Gao F#, Liu LX, Yang Y, Chen YY, Duan HQ, Yao YX, Chen ZW, Lu S*, Wang Y* and Yang C*. Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer. Frontiers in Molecular Biosciences, 2021, 8:678753.
4. Yang QY#, Zhang YT#, Xiao JN, Liang YS, Ji P, Wang SJ, Wang Y*, Chen YY*. Age-related immunoreactivity profiles to diverse mycobacterial antigens in BCG vaccinated Chinese population. Front Immunol., 2021, 11:608220.
5. Bao YJ#, Ling Y#, Chen YY#, Tian D, Zhao GP, Zhang XH, Hang H, Li Y, Su B, Lu HZ*, Xu J*, and Wang Y*. Dynamic Anti-Spike Protein Antibody Profiles in COVID-19 Patients. Int J Infect Dis, 2020, 10:S1201-9712(20)32537-6.
6. Tian Y#, Lian C#, Chen YY#, Wei D, Zhang XX, Ling Y*, Wang Y*, and Yeap L-S* (2020). Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays. Cell Discovery, 2020, 6:75.
7. Jin YP#, Dong H#, Xia LL, Yang Y, Zhu YQ, Shen Y, Zheng HJ, Yao CC, Wang Y, Lu S*. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC. J Thorac Oncol., 2019, 14(8):1378-1389.
8. Khanniche A, Zhou L, Jiang B, Song J, Jin YH, Yin J, Wang SJ, Ji P, Shen H, Wang Y*, Xu HJ*. Restored and enhanced memory T cell immunity in Rheumatoid Arthritis after TNFa blocker treatment, Front Immunol., 2019, 10:887.
9. Xia LL#, Liu YY#, Wang Y*. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions. Oncologist., 2019, 24 (Suppl 1):S31-S41.
10. Chen YY#, Xiao JN#, Li Y#, Xiao YJ#, Xiong YQ, Liu Y, Wang SJ, Ji P, Zhao GP, Shen H, Lu SH, Fan XY*, Wang Y*. Mycobacterial lipoprotein Z triggers efficient innate and adaptive immunity for protection against Mycobacterium tuberculosis infection, Front. Immunol., 2019, 9:3190.
11. Zhang MY#, Yao CC#, Cai J#, Liu S, Liu XN, Chen YY, Wang SJ, Ji P, Pan M, Kang ZZ*, Wang Y*. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production. J Transl Med, 2019, 17(1).
12. Liu YY#, Sha W#, Xu SQ, Gui XW, Xia LL, Ji P, Wang SJ, Zhao GP, Zhang X*, Chen YY*, Wang Y. Identification of HLA-A2-restricted mycobacterial lipoprotein Z peptides recognized by T Cells from patients with active tuberculosis infection, Front. Microbiol., 2018, 9:3131.
13. Xiao JN, XiongYQ, Chen YY, Xiao YJ, Ji P, Li Y, Wang SJ, Zhao GP, Cheng QJ, Lu SH* and Wang Y*.Determination of Lipoprotein Z-specific IgA in tuberculosis and latent tuberculosis infection. . Front Cell Infect Mcrobiol,2017,7; 495.
14. Yang X, Wu JB, Liu Y, Xiong Y, Ji P, Wang SJ, Chen Y, Zhao GP, Lu SH, Wang Y*.Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.Tuberculosis,2017,107:119-125.
15. Liu Z, Zeng W, Huang X, Wang S, Zheng J, Pan M, Wang Y*.Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and IgM production in human autoimmune diseases. Sci Rep,2017,7(1):13921.
16. Zhang R, Wu X, Xia X, Khanniche A, Song F, Zhang B*, Wang Y*, Ge H*.OVA12 promotes tumor growth by regulating p53 expression in human cancer cells.Oncotarget,2017,8(32):52854-52865.
17. Yang C, Khanniche A, DiSpirito JR, Ji P, Wang S, Wang Y*, Shen H*.Transcriptome Signatures Reveal Rapid Induction of Immune-Responsive Genes in Human Memory CD8(+) T Cells.Sci Rep,2016,6:27005.
18.Xiao XJ#, Sha W#, Tian ZF#, Chen YY, Ji P, Sun Q, Wang HY, Wang SJ, Fang Y, Wen HL, Zhao HM, Lu J, Xiao HP, Fan XY*, Shen H*, Wang Y*. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis. J Mol Med. (Berl), 2016, 94(7):823-834.
19. Wang Y, Wang XD*. Entosis and Related Forms of Cell Death within Cells. Curr Mol Med. 2015, 15(9):805-809.
20. Ni C#, Chen YH#, Zeng MS#, Pei RJ, Du Y, Tang LQ, Wang MY, Hu YJ, Zhu HY, He MF, Wei XW, Wang S, Ning XK, Wang MN, Wang JF, Ma L, Chen XW, Sun Q, Tang H, Wang Y*, Wang XN*. In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures. Cell Res. 2015, 25(7):785-800.
21. Wang Y, Kissenpfennig A, Mingueneau M, Richelme S, Perrin P, Chevrier S, Genton C, Lucas B, DiSanto JP, Acha-Orbea H, Malissen B*, Malissen M. Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. J Immunol. 2008, 180(3):1565-1575.
22. Wang Y, Hilgert I, Hamm-Baarke A, Richelme M, Gregoire C, Guinamard R, Horejsi V, Angelisova P, Spicka J, Schraven B, Malissen B, Malissen M. Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B cell development and function, Mol Cell Biol., 2005, 25(11): 4455-4465.
課題組長(zhǎng)
滬公網(wǎng)安備 31009102000053號(hào) 滬ICP備18007527號(hào)-1 郵箱：[email protected]